Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
NGNE Neurogene
- 11.710
- -2.810-19.35%
Close Mar 31 16:00 ET
- 12.600
- +0.890+7.60%
Pre 05:25 ET
174.83MMarket Cap-2.74P/E (TTM)
13.830High11.017Low678.77KVolume13.810Open14.520Pre Close7.80MTurnover12.24%Turnover RatioLossP/E (Static)14.93MShares74.49052wk High0.56P/B64.94MFloat Cap11.01752wk Low--Dividend TTM5.55MShs Float1115.000Historical High--Div YieldTTM19.37%Amplitude7.500Historical Low11.496Avg Price1Lot Size
About Neurogene Company
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Company Profile
SymbolNGNE
Company NameNeurogene
Listing DateMar 7, 2014
Founded2007
CEOMr. Richard K. Matros
MarketNASDAQ
Employees107
Fiscal Year Ends12-31
Address535 West 24th Street,5th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10011
Phone1-877-237-5020
Websitehttp://www.neurogene.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel McMinn, PhD
- Executive Chairman of the Board and Chief Executive Officer
- 1.08M
- Christine Mikail Cvijic, J.D.
- President and Chief Financial Officer
- 1.13M
- Dr. Stuart Cobb, PhD
- Chief Scientific Officer
- 784.32K
- Dr. Julie Jordan, M.D.
- Chief Medical Officer
- --
- Donna Cochener
- Senior Vice President and General Counsel
- --
- Rohan Palekar
- Independent Director
- 71.62K
- Robert Keith Woods
- Independent Director
- --
- Dr. Sarah B. Noonberg, M.D.,PhD
- Independent Director
- 62.12K
- Dr. Robert A. Baffi,PhD
- Independent Director
- 64.08K
- Dr. Cory Freedland, PhD
- Independent Director
- --
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
